Zack Lentz has been appointed as Chief Commercial Officer at OPEN Health, a company with a global focus on medical affairs, health economics and outcomes research (HEOR) and market access, patient engagement and consulting services.
In his new role, Lentz will focus on accelerating growth and deepening client partnerships, using his experience of over 20 years of building and leading high-performing teams across the life sciences sector.
Lentz has previously partnered with pharmaceutical and biotech leaders to maximise the value of innovation across the product life cycle in senior leadership roles that include Chief Growth Officer at Inizio Medical and President & Chief Strategy Officer at Vaniam Group,
“Zack’s proven track record of growth leadership and his deep understanding of the life sciences landscape make him an exceptional addition to OPEN Health,” said Matt D’Auria, OPEN Health CEO. “His ability to combine strategic vision with team development will further strengthen our ability to deliver meaningful impact for clients and the patients they serve.”
Lentz commented: “I am thrilled to join OPEN Health at such a pivotal time for the industry. The company’s commitment to connecting science, evidence, access and engagement aligns perfectly with my passion for helping clients realise the full potential of their innovations to improve patients’ lives.”